DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
-4.88%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$266M
AUM Growth
+$266M
Cap. Flow
+$19.1M
Cap. Flow %
7.19%
Top 10 Hldgs %
48.53%
Holding
96
New
9
Increased
25
Reduced
15
Closed
6

Top Buys

1
FATE icon
Fate Therapeutics
FATE
$6.37M
2
APLS icon
Apellis Pharmaceuticals
APLS
$4.09M
3
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
$3.18M
4
MGNX icon
MacroGenics
MGNX
$1.91M
5
TBIO
Translate Bio, Inc. Common Stock
TBIO
$1.84M

Top Sells

1
QNCX icon
Quince Therapeutics
QNCX
$2.78M
2
INDP icon
Indaptus Therapeutics
INDP
$1.81M
3
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.53M
4
NXTC icon
NextCure
NXTC
$1.44M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
$1.19M

Sector Composition

1 Healthcare 92.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RIGL icon
76
Rigel Pharmaceuticals
RIGL
$697M
$295K 0.11%
157,700
+20,100
+15% +$37.6K
KALV icon
77
KalVista Pharmaceuticals
KALV
$678M
$287K 0.11%
24,725
– –
ALDX icon
78
Aldeyra Therapeutics
ALDX
$351M
$264K 0.1%
50,000
– –
LRMR icon
79
Larimar Therapeutics
LRMR
$310M
$226K 0.09%
305,500
+20,000
+7% +$14.8K
BLCM
80
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$210K 0.08%
200,000
+170,000
+567% +$179K
CDTX icon
81
Cidara Therapeutics
CDTX
$1.66B
$199K 0.07%
99,993
-112,773
-53% -$224K
KRTX
82
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$183K 0.07%
11,192
+1,192
+12% +$19.5K
EVLO
83
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$122K 0.05%
+20,000
New +$122K
LCTX icon
84
Lineage Cell Therapeutics
LCTX
$267M
$93K 0.04%
95,000
– –
ADXS
85
DELISTED
Advaxis, Inc.
ADXS
$93K 0.04%
+350,000
New +$93K
RNTX
86
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
$67K 0.03%
99,502
– –
ORMP icon
87
Oramed Pharmaceuticals
ORMP
$90.2M
$51K 0.02%
16,000
– –
INDP icon
88
Indaptus Therapeutics
INDP
$7.19M
– –
-415,989
Closed -$1.81M
NXTC icon
89
NextCure
NXTC
$13.5M
– –
-96,100
Closed -$1.44M
QNCX icon
90
Quince Therapeutics
QNCX
$85.9M
– –
-65,400
Closed -$2.78M
SLGL icon
91
Sol-Gel Technologies
SLGL
$63.5M
– –
-35,000
Closed -$319K
MORF
92
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-60,000
Closed -$1.19M
NGM
93
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-6,265
Closed -$92K
1 2 3
4